CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
about
Immunopathogenesis and neurological manifestations associated to HTLV-1 infectionCSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesisProteome and cytokine serum profiling to diagnose a mycosis fungoides.Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infectionTreatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: A case report.Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy.Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.HTLV-1-associated myelopathy/tropical spastic paraparesis.Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis.Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testingSerum and cerebral spinal fluid levels of chemokines and Th2 cytokines in Schistosoma mansoni myeloradiculopathy
P2860
Q27026230-610C1548-22B6-4E4D-B9AC-F2B363CD287AQ28534309-1CE504F8-A0E3-4D72-8E6F-AACEC691C2AEQ33959656-0AAE3C43-6AFE-42F1-96DF-4CA92DC65C12Q34145669-1F14E1C1-840C-493D-AFA8-7B6FA1E039B1Q36277748-AC55013F-7760-43AA-A5E0-317FE8706A4CQ37646610-F26BB63A-D644-4623-8726-561CCDEF480DQ38874995-D06B74B9-A348-436E-9A71-B42888A7A86DQ39035579-32BDFBA4-9088-49FD-86FF-9CD5266EE294Q45096240-02E17B06-6384-41BB-BD87-171FB1639113Q48726201-3ECF986E-0AB1-4926-A9F6-4E2BE2A1FB48Q58691752-25F8D1E5-397D-4F5C-B305-E65A8AE58752Q58857650-B9357C0D-14E5-478F-B9A5-C735D228BF16
P2860
CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@en
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@nl
type
label
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@en
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@nl
prefLabel
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@en
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@nl
P2093
P1476
CSF-chemokines in HTLV-I-assoc ...... ic effect of interferon-alpha.
@en
P2093
Hiroshi Saito
Isabelle Miyazawa
Juichi Fujimori
Kazuo Fujihara
Koichi Narikawa
Shigeru Sato
Tatsuro Misu
Yasuto Itoyama
P304
P356
10.1016/J.JNEUROIM.2004.10.011
P577
2004-12-15T00:00:00Z